Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma

BACKGROUND: Immunotherapy is an important treatment in oncology, but only a fraction of patients with head and neck squamous cell carcinoma (HNSCC) benefit from it. Therefore, the aim of this study was to identify predictive biomarkers of immunotherapy response for HNSCC in order to improve treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xuanli, Li, Rongrong, Zhang, Lin, Zhu, Guopei, Ren, Dandan, Wu, Lijia, Gong, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620526/
https://www.ncbi.nlm.nih.gov/pubmed/34823553
http://dx.doi.org/10.1186/s13000-021-01147-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620526/
https://www.ncbi.nlm.nih.gov/pubmed/34823553
http://dx.doi.org/10.1186/s13000-021-01147-7

Ejemplares similares